Psyence Biomedical Ltd. ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing nature-derived psilocybin ...

One dose of the active compound in ayahuasca significantly improves depressive symptoms in early stages of a clinical trial, according to a new study. View on euronews ...

Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies ...

The owner of a now-closed smoke shop in downtown McHenry has pleaded guilty and been sentenced to jail time after he was caught with a variety of drugs by a narcotics task force.

The former owner of a McHenry smoke shop has been sentenced to jail time and probation in a felony LSD possession plea deal.

Two Houston men admit to engaging in organized criminal activity that is associated with a convenience store burglary in Bryan two years ago. Plea agreements with the Brazos County district attorney’s ...

The U.S. Food and Drug Administration issued its first formal guidance on how to design and run clinical trials for ...

In two large-scale trials, Compass Pathways' proprietary form of psilocybin improved people's depression symptoms better than controls.

Oregon took a leap into the psychedelic unknown when voters approved regulated psilocybin services nearly six years ago to treat addiction, depression and other illnesses. Since then, thousands of ...

How are the first state-run psilocybin therapy programs going? Plus, psilocybin clinical trials for cancer patients dealing with anxiety.

Compass Pathways' synthetic psilocybin COMP360 clears Phase 3 trials, showing 39% depression reduction in 24 hours for treatment-resistant patients.

House Bill 4040, a sprawling health omnibus from the Oregon House Health Care Committee, is snaking its way through Salem ...